Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is
Stock Chart
Data Provided by Refinitiv. Minimum 15 minutes delayed.